News
Hikma strengthens US Injectables business through acquisition of Custopharm
News
Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine tablets in the US
Recent event
Watch the replay of our Generics Meet the Management event.
2021 Interim Results
Watch our CEO Siggi Olafsson summarise our 2021 half year performance
#OwnYour Career @Hikma
Meet Janaina, Maintenance Planner, Engineering at Hikma Portugal. She loves tackling new challenges every day and using her communications and problem solving skills on the job.
Case study
Our support and impact; improving patient’s access to ritonavir
Insight
Kept out of reach - tackling the enduring challenge of access to medicine
Update
Hikma update regarding COVID-19
Find out more
Who we are. We make high quality medicines and make them accessible to the people that need them.
News
Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA
Find out more
Our commitment to sustainability
Find out more
Our Modern Slavery Act statement.